NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Karo Pharma AB (publ) (ST: KARO)

 
KARO Technical Analysis
4
As on 24th Nov 2022 KARO STOCK Price closed @ 60.70 and we RECOMMEND Buy for LONG-TERM with Stoploss of 56.96 & Strong Buy for SHORT-TERM with Stoploss of 55.61 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

KAROSTOCK Price

Open 60.40 Change Price %
High 61.00 1 Day 0.20 0.33
Low 60.40 1 Week 0.30 0.50
Close 60.70 1 Month 0.20 0.33
Volume 52254 1 Year 4.70 8.39
52 Week High 64.00 | 52 Week Low 50.00
 
ST Sweden Most Active Stocks
TERRNT-B 0.38 %
TANGI 0.01 %
FING-B 0.07 %
SBB-B 6.21 %
OP 0.37 %
PROGEN 0.01 %
LUNE 21.97 6.65%
HDW-B 0.01 %
LIPI 0.08 %
XBRANE 0.17 %
 
ST Sweden Top Gainers Stocks
FEEL 0.09 12.50%
XPEC 2.52 7.69%
MAXF 50.20 6.81%
LUNE 21.97 6.65%
CARY 76.05 5.62%
LOYAL 7.36 5.44%
ZETA 8.15 4.76%
ZETA 8.15 4.76%
SECS 0.45 4.65%
ASPIRE 73.70 3.80%
 
ST Sweden Top Losers Stocks
ALLR 1.55 -26.54%
SARSYS 2.28 -8.06%
INVAJO 5.03 -7.20%
ECOWVE 4.30 -4.44%
CUR 2.17 -3.56%
CUR 2.17 -3.56%
PIEZO 31.90 -3.33%
GPXMED 2.49 -2.73%
ENDO 50.80 -2.68%
ENDO 50.80 -2.68%
 
 
KARO
Daily Charts
KARO
Intraday Charts
Whats New @
Bazaartrend
KARO
Free Analysis
 
KARO Important Levels Intraday
RESISTANCE61.86
RESISTANCE61.49
RESISTANCE61.26
RESISTANCE61.03
SUPPORT60.37
SUPPORT60.14
SUPPORT59.91
SUPPORT59.54
 
KARO Forecast September 2024
4th UP Forecast72.65
3rd UP Forecast68.82
2nd UP Forecast66.45
1st UP Forecast64.08
1st DOWN Forecast57.32
2nd DOWN Forecast54.95
3rd DOWN Forecast52.58
4th DOWN Forecast48.75
 
KARO Weekly Forecast
4th UP Forecast64.17
3rd UP Forecast63.06
2nd UP Forecast62.37
1st UP Forecast61.68
1st DOWN Forecast59.72
2nd DOWN Forecast59.03
3rd DOWN Forecast58.34
4th DOWN Forecast57.23
 
KARO Forecast2024
4th UP Forecast91.05
3rd UP Forecast81.32
2nd UP Forecast75.3
1st UP Forecast69.28
1st DOWN Forecast52.12
2nd DOWN Forecast46.1
3rd DOWN Forecast40.08
4th DOWN Forecast30.35
 
 
KARO Other Details
Segment EQ
Market Capital 12894390272.00
Sector Healthcare
Industry Drug Manufacturers-Specialty & Generic
Offical website >
 
KARO Address
KARO
 
KARO Latest News
 
Your Comments and Response on Karo Pharma AB (publ)
 
KARO Business Profile
Karo Pharma AB (publ) develops and markets prescription drugs and over-the-counter products for pharmacies and retail sector in Sweden, Norway, Denmark, Finland, France, rest of Europe, the United States, and internationally. It offers dermatology products under the Decubal, Fungobase, indy beauty, Lucobase, Mildison, OLIVA, PoxClin, and PROPYLESS brands; intimate care products under the HemoClin, Multi-Gyn, Multi-Mam, Pevaryl, Scheriproct, and Selexid brand names; and foot care products under the CCS, Cortimyk, Footner, Nailner, Pevaryl, and wortie brands. The company also provides pain, cough, and cold products under the Bronkyl, Dolerin, Ibux, Mollipect, Nazamer, nozoil, Paracet, and Viruseptin brand names; prescription drugs under the Burinex, Centyl, and Kaleorid brands; and wellness products under the Flux, Allévo, Dosett, Dax, antibac, BAMSE, Betavivo, and Lactocare brands. The company sells its products through direct sales organisations and a network of distributors, as well as online. The company was formerly known as Karo Bio AB (publ) and changed its name to Karo Pharma AB (publ) in March 2016. Karo Pharma AB (publ) was incorporated in 1987 and is headquartered in Stockholm, Sweden. Address: Klara Norra Kyrkogata 33, Stockholm, Sweden, 111 22
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service